The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%. The increasing adoption of orally disintegrating tablets, growing generics market, and emergence of new superdisintegrants for the pharmaceutical industry are the factors driving the market for superdisintegrants. 更多
